Executive team

Agustin Fernandez

Chief Executive Officer

David Brindley, DPhil, MEng; PG Cert, (IP), RAC (US), FRSA, FRSB

Chief Operating Officer

Edward Gershburg, PhD

Chief Technology Officer

Luis Rios-Nogales, MD, PhD, MBA

Chief Development and Medical Officer

Kelly Smith MD, MHS

Global Safety Officer

Gerhard Hager, PhD

Head of Non-Clinical Development

Uwe Michaelis, PhD

IMPD Submission Operations

Kerstin Westritschnig, MD

Head of Clinical Development

Konstantin Kousoulas PhD

VP of Scientific Affairs

Cecilia Huaman, MPH, Ph.D

Director Immunology and Diagnostics

Christian Wallasch, PhD

Head, Global Operations

Quinn Steele

Head of GxP and Regulatory E-Systems

Diane Abbitt, Esq

Patient Advocate

David B. Mixner

Diversity Outreach Advisor

Scientific Advisory Board

Paul Predki, PhD

SAB Chair, Biotech executive, co-founder and CTO of Iridia Inc.

Rahul Singhvi, ScD, MBA

Operating Partner, Flagship Pioneering

Lional Raj, MD

Medical Director, Department of Cornea and Refractive Surgery, Dr. Agarwal’s Eye Hospital, India

Daniel J.J. Carr, PhD

Dean of Research, McGee Eye Institute and Optometry, University of Oklahoma, USA

Georg Holländer, MA, MD, FMedSci, FRCPCH, FHM Pediatrics

Chair, Department of Pediatrics, University of Oxford, Oxford, UK

Todd Margolis, MD, PhD

Chair, Department of Ophthalmology, Washington University, St. Louis, MO, USA

Jim Robinson, BS, MS

Industry Consultant

David I. Bernstein, MD, MA

Professor of Pediatric Infectious Diseases at Cincinnati Children’s Hospital Medical Center